Results 181 to 190 of about 51,957 (233)

Drug-coated balloons versus drug-eluting stents in patients with small coronary artery disease: an updated meta-analysis. [PDF]

BMC Cardiovasc Disord
Abdelaziz A, Elsayed H, Atta K, Desouky M, Gomaa M, Kadhim H, Mechi A, Abdelaziz M, Ezzat M, Mabrouk MA, Ellabban MH, Zawaneh EA, Hafez A, Elnaggar MY, Sena AO, Bahnasy A, Singer E.   +16 more
europepmc   +1 more source

Self‐expandable sirolimus‐eluting stents compared to second‐generation drug‐eluting stents for the treatment of the left main: A propensity score analysis from the SPARTA and the FAILS‐2 registries

, 2018
Antonio Montefusco, Fabrizio D’Ascenzo, Sebastiano Gili, Grzegorz Smołka, Alaide Chieffo, Andreas Baumbach, Javier Escaned, Paolo Sganzerla, Francesco Tomassini, Gioel Gabrio Secco, Fabrizio Ugo, Corrado Tamburino, Annamaria Nicolino, Massimo Mancone, Arnaldo Poli, Kuan Leong Yew, Plinio Cirillo, Wojciech Wańha, Luigi Emilio Pastormerlo, Roberto Di Summa, Gennaro Sardella, Antonio Colombo, Fiorenzo Gaïta, Bernardo Cortese   +23 more
openalex   +2 more sources

Efficacy and safety of drug-coated balloon angioplasty in proximal LAD stenosis with distal myocardial bridge: a 12-month comparative study with drug-eluting stents. [PDF]

Front Cardiovasc Med
Wu X, Wu M, Huang H, Liu Z, Huang H, Wang L.   +5 more
europepmc   +1 more source

Dedicated Bifurcation Stents vs. Regular Drug-Eluting Stents in Coronary Bifurcation Treatment: A Systematic Review and Meta-Analysis of 1-Year and 4-Year Outcomes, Including Left Main and Non-Left Main Subgroup Comparisons. [PDF]

Biomedicines
Bil J, Kern A, Gziut-Rudkowska AI, Zalewski J, Bojko K, Gil RJ.   +5 more
europepmc   +1 more source

Symptomatic vertebral artery stenting with the use of bare metal and drug eluting stents

, 2009
Paluszek, Piotr, Odrowąż-Pieniążek, Piotr, Musiałek, Piotr, Przewłocki, Tadeusz, Kabłak-Ziembicka, Anna, Motyl, Rafał, Tekieli, Łukasz, Leśniak-Sobelga, Agata, Żmudka, Krzysztof, Tracz, Wiesława   +9 more
openalex   +1 more source

Benefit of Drug-eluting Coronary Stents in Reducing In-stent Restenosis

, 2004
David R. Holmes
openalex   +1 more source

Long term outcomes of drug-coated balloons versus drug-eluting stents in patients with small vessel coronary artery disease. [PDF]

Indian Heart J
Refaat H, Arab M.
europepmc   +1 more source

A Strategy for the In-Silico Assessment of Drug Eluting Stents: A Comparative Study for the Evaluation of Retinoic Acid as a Novel Drug Candidate for Drug Eluting Stents. [PDF]

IEEE Open J Eng Med Biol
Pleouras DS, Loukas VS, Karanasiou G, Katsouras C, Semertzioglou A, Moulas AN, Michalis LK, Fotiadis DI.   +7 more
europepmc   +1 more source

Modeling of biodegradable stents [PDF]

, 2011
De Beule, Matthieu, Debusschere, Nic, Dubruel, Peter, Segers, Patrick, Verhegghe, Benedict   +4 more
core   +1 more source

Outcomes of first-generation versus second-generation drug-eluting stents in calcified coronary lesions: A meta-analysis. [PDF]

Narra J
Rohman MS, Fajar JK, Widyaningsih MC, Aziizah YN, Khasanah UA, Nendro FE, Beting EG, Tanaem VS, Jannati D, Putri WM, Tamara F.   +10 more
europepmc   +1 more source